Table 2.
Cohort BMDD median outcomes from patients with T2DM.
| Patients with diabetes mellitus type 2 (T2DM) | Adult reference1 | |||
|---|---|---|---|---|
| Total cohort (n=26) | HbA1C<7% (n=10) | HbA1C>7% (n=16) | (n=25) | |
| Cn.CaMean (wt%) | 23.25 (22.90; 23.89) | 22.96 (22.79; 23.88) | 23.43 (22.92; 23.95) | 23.31 (23.12; 23.67) |
| Cn.CaPeak (wt%) | 24.09 (23.74; 24.61) | 23.92 (23.70; 24.52) | 24.44 (23.74; 24.61) | 24.09 (23.92; 24.44) |
| Cn.CaWidth (Δwt%) | 3.81 (3.64; 4.33) | 3.90 (3.64; 4.51) | 3.73 (3.51; 4.16) | 3.81 (3.81; 3.99) |
| Cn.CaLow (%B.Ar) | 4.44 (3.33; 5.33) | 4.26 (3.79; 5.81) | 4.56 (3.12; 5.27) | 4.61 (3.96; 5.48) |
| Cn.CaHigh (%B.Ar) | 3.93 (2.60; 7.36) | 3.04 (2.48; 7.41) | 5.31 (2.51; 7.34) | 3.99 (3.17; 5.56) |
| Ct.CaMean (wt%) | 22.91 (22.44; 23.31) | 22.82 (22.33; 23.49) | 22.92 (22.49; 23.21) | 23.04 (22.68; 23.24) |
| Ct.CaPeak (wt%) | 23.74 (23.29; 24.02) | 23.66 (23.09; 24.22) | 23.79 (23.44; 23.98) | 23.92 (23.66; 24.26) |
| Ct.CaWidth (Δwt%) | 4.07 (3.73; 4.27) | 3.99 (3.79; 4.55) | 4.07 (3.66; 4.25) | 4.07 (3.90; 4.25) |
| Ct.CaLow (%B.Ar) | 5.41 (3.99; 6.60) | 4.68 (3.68; 6.52) | 5.66 (4.47; 6.66) | 5.18 (4.80; 6.35) |
| Ct.CaHigh (%B.Ar) | 3.04 (1.52; 4.61) | 2.28 (1.42; 4.86) | 3.42 (1.73; 4.51) | 3.70 (2.31; 4.78) |
1
Adult reference group comprised healthy men and women aged 30 to 95 years[22].
Data are median (25th, 75th percentiles). Comparison to reference as well as subgroup comparison by HbA1c failed statistical significance.